Medscape

Immune Status Does Not Affect Thyroid Cancer Prognosis

Differentiated thyroid cancer shows a comparable prognosis in patients with immunocompromised vs immunocompetent status, a ...
CURE

Understanding Stage 3 Papillary Thyroid Cancer: A Patient-Oncologist Discussion Guide

This guide provides an informative and educational overview of stage 3 papillary thyroid cancer (PTC) to help drive a ...
Medindia on MSN

Study Warns of Rising Thyroid Cancer Rates Worldwide

The study's projections reveal that increases in new cases will continue in most regions. Women will remain ...

FDA approves label update for UNLOXCYT™ (cosibelimab-ipdl) based on longer-term data that demonstrated improved clinical outcomes in advanced cutaneous squamo…

As the first and only PD-L1 immune checkpoint inhibitor approved for aCSCC, UNLOXCYT is an evolution in checkpoint inhibition ...
Le Lézard

Bristol Myers Squibb Data at ASH 2025 Showcase Potential of Hematology Pipeline and Build Momentum for Next Generation Portfolio

Bristol Myers Squibb today announced the presentation of more than 95 data disclosures, including 27 oral presentations, across company-sponsored studies and external collaborations at the 67th ...
Le Lézard

FDA approves label update for UNLOXCYTtm (cosibelimab-ipdl) based on longer-term data that demonstrated improved clinical outcomes in advanced cutaneous squamous cell carcinoma ...

As the first and only PD-L1 immune checkpoint inhibitor approved for aCSCC, UNLOXCYT is an evolution in checkpoint inhibition, offering a balance of durable clinical responses and acceptable ...